Sodium Glucose Transporter 2 Inhibitors and Clinical Outcomes in Patients with Left Ventricular Assist Devices

Purpose: An impact of sodium glucose transporter 2 inhibitors (SGLT2-i) on mortality and hospitalizations in patients supported with left ventricular assist device (LVAD) is unknown.

Source: The Journal of Heart and Lung Transplantation - April 1, 2024 Category: Transplant Surgery Authors: , E. Masalha, E. Maor, E. Potapov, V. Falk, M. M üller, C. Hoermandinger, I. Just-Lauer, F. Schoenrath, J. Mulzer Source Type: research